EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
68 hedge funds and large institutions have $489M invested in Eagle Pharmaceuticals, Inc. in 2015 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
63% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 8
Holders
68
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$33M | |
| 2 | +$30.8M | |
| 3 | +$26.5M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$13.3M |
| 5 |
Morgan Stanley
New York
|
+$8M |
Top Sellers
| 1 | -$10.7M | |
| 2 | -$8.94M | |
| 3 | -$7.33M | |
| 4 |
SLG
Stanley-Laman Group
Berwyn,
Pennsylvania
|
-$4.56M |
| 5 |
DM
Deerfield Management
New York
|
-$4.41M |